Reported Reactions

Devices › Suture, surgical, absorbable, polydioxanone

Device brand name · Suture surgical absorbable polydioxanone

Sfx Spi Pds+ Bi Vio 14in2 Usp1 D/A Ctx: medical device reports filed with FDA

183 reports name it, 2023–2026. Manufacturer given most often on reports: Ethicon. Product code NEW.

183
device reports naming the brand
0% of all MAUDE reports · about 55 a year
101
reports, 12 months to August 2026
34 in the 12 months before
99.5%
classified as malfunction
76.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

183 medical device reports received by FDA name the brand "Sfx Spi Pds+ Bi Vio 14in2 Usp1 D/A Ctx" (suture surgical absorbable polydioxanone); the manufacturer given most often on reports is Ethicon; received from March 2023 to May 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

101 reports arrived in the 12 months to August 2026, up 197% from 34 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.5%) and injury (0.5%); across all suture, surgical, absorbable, polydioxanone reports (product code NEW) death is recorded in 0.3% and malfunction in 76.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are material separation (68.9%), break (17.5%) and positioning failure (16.4%). The patient problems coded most often are foreign body in patient and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01326Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 9Apr 2023: 11May 2023: 1Jun 2023: 4Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 2Dec 2023: 12024Jan 2024: 8Feb 2024: 1Mar 2024: 8Apr 2024: 3May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 2Apr 2025: 10May 2025: 0Jun 2025: 5Jul 2025: 0Aug 2025: 17Sep 2025: 0Oct 2025: 9Nov 2025: 21Dec 2025: 52026Jan 2026: 0Feb 2026: 26Mar 2026: 4Apr 2026: 24May 2026: 12Jun 2026: 0Jul 2026: 0Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

035692023: 2820232024: 2020242025: 6920252026: 662026

Event type and report source

Event type, as classified on the report

Death0%0
Injury0.5%1
Malfunction99.5%182
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%183
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 16,088 reports carrying product code NEW. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Material separation12668.9%19.8%
Breakthe device broke3217.5%50.7%
Positioning failure3016.4%2.9%
Defective component52.7%0.6%
Material integrity problema problem with the device material31.6%2.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Foreign body in patientpart of a device left in the patient10.5%
Pocket erosion10.5%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureSfx Spi Pds+ Bi Vio 14in2 Usp1 D/A CtxProduct code NEWAll MAUDE reports
Reports18316,08826,136,888
Share of that pool—1.1%0%
Classified as death, per 1,000 reports039
Classified as injury0.5%21.2%36.2%
Classified as malfunction99.5%76.8%62.3%
Filed by the manufacturer100%99.4%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code NEW

BrandReportsLatest 12 monthsClassified as death
Stratafix9256470.1%
Sfx Sym Pds+ Uni Vio 18in 1 S/A Ct42700%
Sfx Sym Pds+ Uni Vio 18in 1 S/A Ctb-134300%
Sfx Sym Pds+ Uni Vio 18in 1 S/A Ctx30800%
Sfx Sym Pds+ Uni Vio 18in 0 S/A Ct-130200%
Stratafix Symmetric Pds Plus Knotless Tissue Control Device27000%
Sfxspi Pds+ Bi Vio 14in2 1 Da Ctx26000%
Sfx Sym Pds+ Uni Vio 18in 1 S/A Ct-122000.5%
Sfx Sym Pds+ Uni Vio 18in 0 S/A Ct20700%
Pds2111990%
Stratafix Unknown198150.5%
Stratafix Knotless Tissue Control Device22500.4%
Pds Plus Antibacterial Polydioxanone Suture15600%
Suture Unknown469390.6%
Absorbable Surgical Suture Usp361270%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Sfx Spi Pds+ Bi Vio 14in2 Usp1 D/A Ctx reports

How many FDA reports name Sfx Spi Pds+ Bi Vio 14in2 Usp1 D/A Ctx?

183 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 101 in the latest 12 months.

What kinds of events are reported?

malfunction (99.5%) and injury (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

material separation (68.9%), break (17.5%), positioning failure (16.4%), defective component (2.7%) and material integrity problem (1.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Sfx Spi Pds+ Bi Vio 14in2 Usp1 D/A Ctx was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.